I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Vaitekenaite, Vilmante
12
results:
Search for persons
X
Format
Online (12)
Mediatypes
Articles (Online) (8)
OpenAccess-fulltext (4)
Languages
english (9)
Sorted by: Relevance
Sorted by: Year
?
1
AML-377 Venetoclax in Combination With Low-Dose Cytarabine ..:
Daukėlaitė, Guoda
;
Vasilevska, Dominika
;
Vaitekėnaitė, Vilmantė
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S293-S294 , 2023
Link:
https://doi.org/10.1016/..
?
2
POSTER: MM-445 Genetic Abnormalities in a Real-World Cohort..:
Vaitekenaite, Vilmante
;
Peceliunas, Valdas
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S220 , 2023
Link:
https://doi.org/10.1016/..
?
3
POSTER: AML-377 Venetoclax in Combination With Low-Dose Cyt..:
Daukėlaitė, Guoda
;
Vasilevska, Dominika
;
Vaitekėnaitė, Vilmantė
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S160 , 2023
Link:
https://doi.org/10.1016/..
?
4
Immunogenicity and clinical effectiveness of mRNA vaccine b..:
Kevličius, Lukas
;
Šablauskas, Karolis
;
Maneikis, Kazimieras
...
British Journal of Haematology. 204 (2023) 2 - p. 497-506 , 2023
Link:
https://doi.org/10.1111/..
?
5
MM-445 Genetic Abnormalities in a Real-World Cohort of Mult..:
Vaitekenaite, Vilmante
;
Peceliunas, Valdas
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S499-S500 , 2023
Link:
https://doi.org/10.1016/..
?
6
Venetoclax-based salvage therapy followed by Venetoclax and..:
Zucenka, Andrius
;
Vaitekenaite, Vilmante
;
Maneikis, Kazimieras
...
Bone Marrow Transplantation. 56 (2021) 11 - p. 2804-2812 , 2021
Link:
https://doi.org/10.1038/..
?
7
Venetoclax in combination with low dose Cytarabine and Acti..:
Daraskevicius, Justinas
;
Everatt, Veronika
;
Vaitekenaite, Vilmante
...
Leukemia Research. 111 (2021) - p. 106692 , 2021
Link:
https://doi.org/10.1016/..
?
8
Outcomes of relapsed or refractory acute myeloid leukemia p..:
Zucenka, Andrius
;
Pileckyte, Regina
;
Trociukas, Igoris
...
European Journal of Haematology. 106 (2020) 1 - p. 105-113 , 2020
Link:
https://doi.org/10.1111/..
?
9
Gilteritinib in combination with venetoclax, low dose cytar..:
Žučenka, Andrius
;
Pileckytė, Regina
;
Maneikis, Kazimieras
...
info:eu-repo/semantics/altIdentifier/doi/10.1097/01.HS9.0000845256.68897.e2. , 2022
Link:
https://repository.vu.lt..
?
10
VTD-PACE gydymo rezultatų analizė (atlikus/neatlikus kamien..:
Vaitekėnaitė, Vilmantė
info:eu-repo/semantics/altIdentifier/doi/10.15388/Proceedings.2020.1. , 2020
Link:
https://repository.vu.lt..
?
11
VTD-PACE gydymo rezultatų analizė (atlikus/neatlikus kamien..:
Vaitekėnaitė, Vilmantė
info:eu-repo/semantics/altIdentifier/doi/10.15388/Proceedings.2020.1. , 2020
Link:
http://vu.oai.elaba.lt/d..
?
12
VTD-PACE gydymo rezultatų analizė (atlikus/neatlikus kamien..:
Vaitekėnaitė, Vilmantė
info:eu-repo/semantics/altIdentifier/doi/10.15388/Proceedings.2020.1. , 2020
Link:
http://vu.oai.elaba.lt/d..
1-12
